Cargando…
Expression profiling to predict outcome in breast cancer: the influence of sample selection
Gene expression profiling of tumors using DNA microarrays is a promising method for predicting prognosis and treatment response in cancer patients. It was recently reported that expression profiles of sporadic breast cancers could be used to predict disease recurrence better than currently available...
Autores principales: | Gruvberger, Sofia K, Ringnér, Markus, Edén, Patrik, Borg, Åke, Fernö, Mårten, Peterson, Carsten, Meltzer, Paul S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154130/ https://www.ncbi.nlm.nih.gov/pubmed/12559041 http://dx.doi.org/10.1186/bcr548 |
Ejemplares similares
-
The CD44(+)/CD24(- )phenotype is enriched in basal-like breast tumors
por: Honeth, Gabriella, et al.
Publicado: (2008) -
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers
por: Olsson, Eleonor, et al.
Publicado: (2011) -
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
por: Jumppanen, Mervi, et al.
Publicado: (2007) -
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data
por: Saal, Lao H, et al.
Publicado: (2002) -
Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors
por: Sjöström, Martin, et al.
Publicado: (2018)